Addressing Depression in Maintenance Hemodialysis Patients

In end-stage renal disease, over 90% of kidney function has been lost. Hemodialysis has long been a solution to prolong the life of end-stage renal disease patients. Depressive symptoms and distress are very common in chronic hemodialysis patients with end-stage renal disease, with an estimated prevalence rate of 20 to 70%. Longitudinal studies have shown

Read more...

EPA + DHA Associated with 25% Lower Risk of Depressive Symptoms in US Adults

Substantial evidence links low blood concentrations of long-chain PUFAs (LC-PUFAs), especially n-3 LC-PUFAs, to the risk of depressive illness, yet the data are inconsistent. For example, serum n-3 LC-PUFAs were not associated with severe depression in middle-aged Finnish men, but were significantly lower in patients with recurrent depressive illness. Others have reported significantly lower concentrations

Read more...

EPA and DHA Intakes Linked to Better Cognition and Gray Matter Volume in Older Adults

DHA is critical to the development of brain structure and function, neurotrophic factor expression, neurogenesis, neurite outgrowth, synaptogenesis and plasticity and other aspects of a healthy brain. Studies suggest that infants whose mothers have higher DHA status have improved cognition and attention. Further, the occurrence of behavioral and psychiatric disorders has been associated with lower

Read more...